Clinical Trial Update: Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of topical diclofenac on outcomes in breast cancer patients treated with capecitabine for Hand and Foot Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hand and Foot Syndrome

Drugs mentioned

• Capecitabine (capecitabine)
• Diclofenac topical (diclofenac)

Snippet

Sponsor: German University in Cairo | Conditions: Hand and Foot Syndrome | Phase 2 | Status: COMPLETED